| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |